Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 186

Similar articles for PubMed (Select 23190084)

1.

Characteristics of elderly hepatitis C virus-associated hepatocellular carcinoma patients.

Kumada T, Toyoda H, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Tada T, Tanaka J.

J Gastroenterol Hepatol. 2013 Feb;28(2):357-64. doi: 10.1111/jgh.12057.

PMID:
23190084
2.

A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis.

El-Serag HB, Kanwal F, Davila JA, Kramer J, Richardson P.

Gastroenterology. 2014 May;146(5):1249-55.e1. doi: 10.1053/j.gastro.2014.01.045. Epub 2014 Jan 23.

3.
4.

Comparison of prognosis by viral etiology in patients with hepatocellular carcinoma after radiofrequency ablation.

Chen PH, Kao WY, Chiou YY, Hung HH, Su CW, Chou YH, Huo TI, Huang YH, Wu WC, Chao Y, Lin HC, Wu JC.

Ann Hepatol. 2013 Mar-Apr;12(2):263-73.

PMID:
23396738
5.
6.

Close association between high serum ALT and more rapid recurrence of hepatocellular carcinoma in hepatectomized patients with HCV-associated liver cirrhosis and hepatocellular carcinoma.

Tarao K, Rino Y, Takemiya S, Tamai S, Ohkawa S, Sugimasa Y, Miyakawa K, Morinaga S, Yoshida M, Shibuya A, Kokubu S, Kakita A, Endo O.

Intervirology. 2000;43(1):20-6.

PMID:
10773734
7.

Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.

Pompili M, Rapaccini GL, Covino M, Pignataro G, Caturelli E, Siena DA, Villani MR, Cedrone A, Gasbarrini G.

Cancer. 2001 Jul 1;92(1):126-35.

PMID:
11443618
8.

Serum alanine aminotransferase levels and survival after hepatectomy in patients with hepatocellular carcinoma and hepatitis C virus-associated liver cirrhosis.

Tarao K, Rino Y, Takemiya S, Ohkawa S, Sugimasa Y, Miyakawa K, Tamai S, Masaki T, Hirokawa S, Kameda Y, Nagaoka T, Okamoto N, Kokubu S, Yoshida M, Kakita A.

Cancer Sci. 2003 Dec;94(12):1083-90.

PMID:
14662024
9.

Comparison of hepatocellular carcinoma with cirrhosis patients undergoing hepatic resection between hepatitis B and C infection.

Shiba H, Ishida Y, Fujiwara Y, Wakiyama S, Gocho T, Ito R, lida T, Suzuki F, Furukawa K, Haruki K, Misawa T, Yanaga K.

Hepatogastroenterology. 2013 Oct;60(127):1746-8.

PMID:
24634946
10.

Incidence of hepatocellular carcinoma in HCV-infected patients with normal alanine aminotransferase levels categorized by Japanese treatment guidelines.

Harada N, Hiramatsu N, Oze T, Yamada R, Kurokawa M, Miyazaki M, Yakushijin T, Miyagi T, Tatsumi T, Kiso S, Kanto T, Kasahara A, Oshita M, Mita E, Hagiwara H, Inui Y, Katayama K, Tamura S, Yoshihara H, Imai Y, Inoue A, Hayashi N, Takehara T.

J Gastroenterol. 2013 Apr;48(4):535-43. doi: 10.1007/s00535-012-0657-1. Epub 2012 Sep 14.

PMID:
22976932
11.

Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis.

Tarao K, Rino Y, Ohkawa S, Shimizu A, Tamai S, Miyakawa K, Aoki H, Imada T, Shindo K, Okamoto N, Totsuka S.

Cancer. 1999 Aug 15;86(4):589-95.

PMID:
10440686
12.

Combination PEG-IFN a-2b/ribavirin therapy following treatment of hepatitis C virus-associated hepatocellular carcinoma is capable of improving hepatic functional reserve and survival.

Ishikawa T, Higuchi K, Kubota T, Seki K, Honma T, Yoshida T, Kamimura T.

Hepatogastroenterology. 2012 Mar-Apr;59(114):529-32. doi: 10.5754/hge10867.

PMID:
22024226
13.

Close association between high serum alanine aminotransferase levels and multicentric hepatocarcinogenesis in patients with hepatitis C virus-associated cirrhosis.

Tarao K, Rino Y, Ohkawa S, Tamai S, Miyakawa K, Takakura H, Endo O, Yoshitsugu M, Watanabe N, Matsuzaki S.

Cancer. 2002 Mar 15;94(6):1787-95.

14.

Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.

Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K.

Scand J Gastroenterol. 2008;43(7):849-56. doi: 10.1080/00365520801935459.

PMID:
18584524
15.

Risk factors for hepatocellular carcinoma in patients with drug-resistant chronic hepatitis B.

Jun CH, Hong HJ, Chung MW, Park SY, Cho SB, Park CH, Joo YE, Kim HS, Choi SK, Rew JS.

World J Gastroenterol. 2013 Oct 28;19(40):6834-41. doi: 10.3748/wjg.v19.i40.6834.

16.

Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.

Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kanamori A, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J.

J Gastroenterol Hepatol. 2008 Mar;23(3):459-66. Epub 2007 Sep 14.

PMID:
17854425
17.

Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levels.

Kumada T, Toyoda H, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kanamori A, Atsumi H, Takagi M, Nakano S, Arakawa T, Fujimori M.

J Hepatol. 2009 Apr;50(4):729-35. doi: 10.1016/j.jhep.2008.11.019. Epub 2009 Jan 6.

PMID:
19232448
18.

Comparison of outcomes between patients with alcoholic cirrhosis and those with hepatitis C virus-related cirrhosis.

Toshikuni N, Izumi A, Nishino K, Inada N, Sakanoue R, Yamato R, Suehiro M, Kawanaka M, Yamada G.

J Gastroenterol Hepatol. 2009 Jul;24(7):1276-83. doi: 10.1111/j.1440-1746.2009.05851.x. Epub 2009 Apr 6.

PMID:
19486451
19.

Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death.

Degos F, Christidis C, Ganne-Carrie N, Farmachidi JP, Degott C, Guettier C, Trinchet JC, Beaugrand M, Chevret S.

Gut. 2000 Jul;47(1):131-6.

20.

Alanine aminotransferase level as a predictor of hepatitis C virus-associated hepatocellular carcinoma incidence in a community-based population in Japan.

Suruki R, Hayashi K, Kusumoto K, Uto H, Ido A, Tsubouchi H, Stuver SO.

Int J Cancer. 2006 Jul 1;119(1):192-5.

PMID:
16432841
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk